Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-04991532 dose-ranging study with sitagliptin and placebo in adults with type 2 diabetes on metformin
2011-000602-22Phase 2Completed
- Sponsor
- Pfizer
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing PF-04991532 once daily + metformin, Sitagliptin once daily + metformin and Placebo once daily + metformin (3 arms). Primary endpoint: Change from baseline in HbA1c. Started May 2011; status: completed.
02
Drugs
PF-04991532sitagliptinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2011-000602-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000602-22.